ArrowMark Partners is an investment management firm that offers a range of investment strategies across equities and fixed income for institutional investors, financial intermediaries, and high-net-worth individuals. The firm focuses on providing specialized investment solutions with an emphasis on fundamental research and a disciplined investment process.

Karen Reidy

David Corkins

ArrowMark Partners

ArrowMark Commercial Real Estate Finance Partners

ArrowMark Partners is an employee-owned asset management firm founded in 2007. Today, ArrowMark manages $21.4 billion* in assets on behalf of a broad array of institutional clients and professional asset allocators across alternative credit and capacity-constrained equity strategies, as well as through the management of broadly syndicated and middle-market CLO Funds. Our unique approach, based on the team’s collective experience navigating market cycles, provides extensive insights across the capital structure and a skilled understanding of how to manage complex risk/reward tradeoffs through fundamental research.*As of 9/30/2023. CRE AUM includes commercial mortgage loans that ArrowMark or its affiliate has originated and/or currently manages on behalf of insurance companies and other institutional investors.

Xometry

Ginkgo Bioworks

Shift

NexImmune

Orchard Therapeutics

Latch

Lyra Therapeutics

MarkLogic

Syndax Pharmaceuticals

Starry

Taysha Gene Therapies

4D Molecular Therapeutics

Absci

Invivyd

Amunix

ArcherDX

Moderna

Twilio

ORIC Pharmaceuticals

Precision BioSciences

Metric
Company Name	ArrowMark Partners
Symbol
MSH ID	COM:ARROWMARKPARTNERS
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Financial Services
Country	US
Stage
Employee Count	109
Website	arrowmarkpartners.com
LinkedIn	arrowmarkpartners
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ARROWMARKPARTNERS

ArrowMark Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue